Enter assignee name

EPO Patents = 1

Forward Citations = 91

Loading Chart...

4 inventors (with patents filed for the assignee):

Sandip Panicker (8 out of 22 patents)

Graham Parry (8 out of 24 patents)

Peter Van Vlasselaer (8 out of 19 patents)

4. Nancy E Stagliano (8 out of 41 patents)

5. Ashkan Javaherian (1 patent)

6. Guillermo Muñoz Elias (0 patent)

7. Stefan Irion (0 patent)

8 patents: Sort by Forward Citations

1. 9562106 - Anti-complement C1s antibodies and methods of inhibiting complement C1s activity (2017-02-07),

2. 9562092 - Methods of inhibiting complement C4 activation with anti-complement C1s antibodies (2017-02-07),

3. 9512233 - Anti-complement C1s antibodies and methods of inhibiting complement C1s activity (2016-12-06),

4. 9206259 - Methods of inhibiting complement C4 activation with anti-complement C1S antibodies (2015-12-08),

5. 9074004 - Methods of inhibiting activation of complement component C4 with anti-C1s antibodies (2015-07-07),

6. 9074003 - Methods of inhibiting activation of complement component C4 with anti-C1s antibodies (2015-07-07),

7. 8945562 - Anti-complement C1s antibodies (2015-02-03),

8. 8877197 - Anti-complement C1s (2014-11-04),

True North Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing novel therapies for rare diseases. The company's leading drug candidate, TNT009, is being investigated for the treatment of rare autoimmune diseases. True North Therapeutics is dedicated to improving the lives of patients with unmet medical needs through innovative and targeted therapies.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

8 Patents

#116 in South San Francisco, CA

#8,302 in California

#34,944 in US

South San Francisco, CA, United States of America

True North Therapeutics, Inc.